ENKAM PHARMACEUTICALS ApS: Financial statements 2018
CVR: 25812921
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
ENKAM PHARMACEUTICALS ApS (CVR 25812921) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -275,740 and a net result of DKK -293,665 compared with DKK -277,379 the year before. Equity in the 2018 report amounted to DKK -1,179,474.
- Gross Profit
- DKK -275,740
- Profit/Loss
- DKK -293,665
- Equity
- DKK -1,179,474
- Total Assets
- DKK 7,753
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -276 t. | -294 t. | -1.2 mio. | 0 |
| 2017 | - | -239 t. | -277 t. | -886 t. | 0 |
| 2016 | - | -272 t. | -345 t. | -608 t. | 0 |
| 2015 | - | -426 t. | -488 t. | -263 t. | - |
| 2014 | - | 4.7 mio. | 2.8 mio. | -1.9 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
ENKAM PHARMACEUTICALS ApS has published its annual report for 2017. Gross profit came to DKK -239,433, and the net result was DKK -277,379.
As of May 31, 2018, Jan-Eric Østerlund has left the board of directors of ENKAM PHARMACEUTICALS ApS.
As of May 31, 2018, Sven-Erik Lennart Nilsson has left the board of directors of ENKAM PHARMACEUTICALS ApS.
As of May 31, 2018, Sven-Erik Lennart Nilsson is registered as adm. dir. of ENKAM PHARMACEUTICALS ApS.
As of May 31, 2018, Morten Albrechtsen has stepped down as director of ENKAM PHARMACEUTICALS ApS.
As of May 31, 2018, Robert George Mansfield has stepped down as chairman of ENKAM PHARMACEUTICALS ApS.
On May 31, 2018, the company changed its name from ENKAM PHARMACEUTICALS A/S to ENKAM PHARMACEUTICALS ApS.
About ENKAM PHARMACEUTICALS ApS
ENKAM PHARMACEUTICALS ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2000. The company has been dissolved on 15 July 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named ENKAM PHARMACEUTICALS A/S. The company has 1 employee (2019). In 2018, the company reported a gross profit of DKK -275,740 and a net result of DKK -293,665 compared with DKK -277,379 the year before. Equity in the 2018 report amounted to DKK -1,179,474.